Calithera Biosciences, Inc. (CALA)
Was developing cancer drugs that targeted tumor cell metabolism
$0.00+0.00%Financial Services
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago+200.0%
The outlook
CALA is trading near its 52-week lows, roughly 22% up from the bottom of its recent range. The stock shows mixed momentum against its moving averages, and analyst sentiment leans bearish overall. The current price sits well below historical levels, reflecting sustained pressure on the stock.
What’s behind the score
Price trendMixed vs its moving averages
52-week range22% of the way from its 52-week low to high
Market cap
$1,461
52-wk high
$0.00
52-wk low
$0.00
50-day avg
$0.00
200-day avg
$0.00
Trailing P/E
—